Detailled Information

Name of the Instrument/Tool Risk perception Questionnaire (RPQ)
First Description

Contreras-Yáñez I, Lavielle P, Clark P, Pascual-Ramos V. Validation of a risk perception questionnaire developed for patients with rheumatoid arthritis. PLoS One. 2019 Jul 22;14(7):e0219921. doi: 10.1371/journal.pone.0219921. PMID: 31329625; PMCID: PMC6645517.

Year 2019
Domains
Concept of constructs Risk perception
Population/Disease Disease specific
Originally developed for Rheumatoid Arthritis (RA)
Other rheumatic diseases
where can be applied (only if validated)
---
Additional population with no rheumatic diseases No
Language: Originally published in English
Available in Language Spanish
REFERENCE IDENTIFICATION
Author/s Contreras-Yáñez I, Lavielle P, Clark P, Pascual-Ramos V.
Title Validation of a risk perception questionnaire developed for patients with rheumatoid arthritis.
Journal PLoS One.
Year 2019
Vol 14
Num 7
Pages e0219921
Country Mexico
Language English
Other references of interest
Link https://academic.oup.com/bmb/article/54/4/779/323616
Brief Description

Communication and interpretation of risk.

Instrument/Tool Translations References
No other References.
DEVELOPER CONTACT INFORMATION
Correspondence to Virginia Pascual-Ramos
E-Mail virtichu@gmail.com
Address Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico,
Website ---
Available ---
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Questionnaire
Brief Description

Risk perception (RP) is defined as a multidimensional phenomenon that describes the individual’s judgment of the likelihood of experiencing something unpleasant. The RPQ assesses RP, and it was developed and validated in Spanish speaking RA patients. It consists of 27 items that were ultimately distributed into 5 dimensions following the conceptual construction:  1) Likelihood to develop RA-related articular and extra-articular manifestations 2), Likelihood to develop RA-related complications, comorbidities and severity, 3) Likelihood to develop RArelated socioeconomic unfavorable consequences, 4) Personal responsibility to develop and prevent RA complications and 5) Patient perception of personal control over the disease.

Number of Items 27
Range 0-100
Responses options/scale No
Developed for ---
PRACTICAL APPLICATION
Method of administration Self-administered
Recommendations to score

The 27 individual items are scored as the length of the VAS measured from the beginning of the line (left side) to the point marked by the patient (0 to 100 mm). The mean of the 27 items was calculated

Score Interpretation Higher scores indicate higher risk perception.
Cut-off points 61.7 mm (> defines presence of RP)
Cut-off points applied to ---
Smallest detectable change if described ---
Smallest detectable change applied to ---
Completion time by the patient 13 minutes
Scoring time by the assessor - minutes
Training to score Not necessary
Strengths Useful in clinical practice & research, Easy to use
Limitations Not widely used
OTHER COMMENTS
Other Comments

For further information, please contact the developers.